Form 4: HealthStream Director Sells Shares Under 10b5-1 Plan
Insider Transaction Filing
HealthStream Inc. Director Linda Rebrovick reported a sale of 2,000 common shares, executed under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Director Linda Rebrovick sold 2,000 shares of HealthStream Inc. common stock.
- The transaction occurred on June 1, 2026.
- The sale was conducted under a Rule 10b5-1 trading plan adopted on November 21, 2025.
- Following the transaction, Rebrovick beneficially owns 54,181 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine insider stock sale executed under a pre-established trading plan, which is a standard practice for managing personal investments.
Negatives
- Director Linda Rebrovick sold 2,000 shares of HealthStream Inc. common stock.
Future Outlook
No specific future outlook or guidance is provided in this filing.
Industry Context
StockSavvy.ai notes that Form 4 filings, particularly those involving Rule 10b5-1 plans, are routine disclosures for insider transactions and do not inherently signal a change in company fundamentals. The use of a 10b5-1 plan indicates pre-planned selling activity, often used by executives to diversify holdings or manage personal finances without violating insider trading rules.
Stakeholder Impact
- Shareholders may note the sale by a director, but the use of a Rule 10b5-1 plan suggests this is pre-planned and not necessarily a reflection of negative sentiment towards the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 11/21/2025 | Date Rule 10b5-1 sales plan was adopted by reporting person. |
| 06/01/2026 | Transaction Date for the sale of common stock. |
| 06/02/2026 | Date of signature for the Form 4 filing. |
Keywords
HealthStream Inc., HSTM, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Director Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.